[Stereotactic radiotherapy for operable stage I non-small cell lung cancer].

Date publication

août 2023

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Auteurs

Membres identifiés du Cancéropôle Est :
Dr MARTIN Etienne

Tous les auteurs :
Martin É, Nicolet C, Boisselier P, Khalifa J, Thureau S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37563012

Résumé

Standard treatment stage of non-small cell lung cancer is currently surgery. For inoperable patients, stereotactic body radiotherapy is the reference treatment. This non-invasive technique has developed considerably and its excellent results in terms of carcinological control and tolerance raise the question of its indication for operable patients, especially for old patients and/or with comorbidities. This article reviews the available data in the literature of the place of stereotactic body radiotherapy for medically operable patients with stage I non-small cell lung cancer.

Mots clés

Cancer bronchique non à petites cellules, Early stage, NSCLC, Non-small cell lung cancer, Radiation therapy, Radiothérapie stéréotaxique, Stade précoce, Stereotactic body radiotherapy

Référence

Cancer Radiother. 2023 08 8;: